跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Docetaze - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Docetaze
Approved
STANDARD
Docetaze
Shilpa Medicare Limited, Unit-4 Formulations Sez
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b4726cd989390227
Company
Shilpa Medicare Limited, Unit-4 Formulations Sez
Type
Standard
Approval Details
Approval Id
b4726cd989390227
Drug Approval Philippines Name
Docetaze
Product Name
Docetaze
Registration Number
DR-XY49012
Brand Name
Docetaze
Generic Name
Docetaxel (as Trihydrate)
Dosage Form
Concentrated Solution for I.V. Infusion
Dosage Strength
20mg/mL (80 mg/ 4mL)
Manufacturer
Shilpa Medicare Limited, Unit-4 Formulations Sez
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Issuance Date
28 February 2024
Expiry Date
28 February 2029
Pharmacologic Category
Antineoplastic Agent (Taxane)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b4726cd989390227
Type
Standard
Back to Philippines FDA Approvals